Device for noninvasive brain biopsies via blood draw moves closer to market approval - The Source

A device aimed at enabling physicians to perform noninvasive blood-based biopsies in adults with brain tumors has received Food and Drug Administration “Breakthrough Device” designation. The device includes Washington University in St. Louis technology.

Related Keywords

Hong Chen ,Ericc Leuthardt ,Drug Administration ,Department Of Neurosurgery ,Mckelvey School Of Engineering ,Washington University In St ,Division Of Neurotechnology ,Washington University ,Cordance Medical Inc ,School Of Medicine ,Mountain View ,Shi Hui Huang Professor ,Washington University School ,Mckelvey School ,Cordance Medical ,